BioGen

Description

Ji Xing Pharmaceuticals Announced Acquisition of BIIB131 From

Biogen

Biogen moves forward with aducanumab launch plans - Drug Discovery and Development

Aducanumab debate: Expert views on Biogen's Alzheimer drug

Environment

FDA chief calls for probe of relationship between agency and Biogen - POLITICO

Biogen opens a branch in Estonia: Europe has lots to learn from

Biogen hi-res stock photography and images - Alamy

Biogen's rare genetic disorder drug gets approval in EU

Responsibility

Contact Us

Mila Announces Collaboration with Biogen to augment the

$ 13.50USD
Score 4.8(712)
In stock
Continue to book